cycloserine has been researched along with Claustrophobia in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 16 (61.54) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Browning, M; Kaldewaij, R; Kappelmann, N; Michael, T; Reinecke, A; Rinck, M; Steudte-Schmiedgen, S; Suesse, M | 1 |
| Alston-Knox, C; Collings, N; Donovan, CL; Farrell, LJ; Garbharran, V; McConnell, H; Oar, EL; Ollendick, TH; Storch, EA; Testa, C; Tiralongo, E; Waters, AM; Zimmer-Gembeck, M | 1 |
| Geller, DA; McGuire, JF; Murphy, TK; Orr, SP; Porth, R; Small, BJ; Storch, EA; Trainor, K; Wilhelm, S | 1 |
| Fang, A; Hofmann, SG; Marques, L; Meuret, AE; Otto, MW; Pollack, MH; Rosenfield, D; Simon, N; Smits, JA; Tart, C | 1 |
| Javitt, DC | 1 |
| Costa, PT; DeBoer, LB; Hofmann, SG; Marques, L; Meuret, AE; O'Cleirigh, C; Otto, MW; Pollack, MH; Rosenfield, D; Simon, NM; Smits, JA | 1 |
| Dowd, S; Hofmann, SG; Marques, L; Meuret, AE; Otto, MW; Pollack, MH; Rosenfield, D; Simon, NM; Smits, JA; Zalta, AK | 1 |
| Dodds, A; Rapp, A; Rynn, M; Walkup, JT | 1 |
| Chags, MH; Crippa, JA; Hallak, JE; Linares, IM; Machado-de-Sousa, JP | 1 |
| Byrne, SP; Hudson, JL; Jones, M; Malhi, GS; Rapee, RM; Richardson, R | 1 |
| Heimberg, RG; Jørstad-Stein, EC | 1 |
| Aupperle, RL; Barth, FX; Cain, SE; Chambers, RJ; Denney, DR; Hale, LR; Savage, CR; Sharp, SC | 1 |
| Hofmann, SG | 2 |
| Choi, DC; Gerardi, M; Ressler, KJ; Rothbaum, BO | 1 |
| Gutner, CA; Hofmann, SG; Weinberger, J | 1 |
| Nave, AM; Stevens, MC; Tolin, DF | 1 |
| Deboer, LB; Handelsman, PR; Hofmann, SG; Otto, MW; Pollack, MH; Powers, MB; Rosenfield, D; Smits, JA; Tart, CD | 1 |
| Lenze, EJ; Levinson, CA; Rodebaugh, TL | 1 |
| Hofmann, SG; Otto, MW; Pollack, MH; Powers, MB; Rosenfield, D; Smits, JA; Tart, CD; Telch, MJ | 1 |
| Miller, G | 1 |
| Anderson, P; Davis, M; Graap, K; Hodges, L; Ressler, KJ; Rothbaum, BO; Tannenbaum, L; Zimand, E | 1 |
| Eisenmenger, K; Hofmann, SG; Meuret, AE; Otto, MW; Pollack, MH; Shiekh, M; Simon, NM; Smits, JA | 1 |
| Dadds, MR; Guastella, AJ; Lovibond, PF; Mitchell, P; Richardson, R | 1 |
| Davis, M; Ressler, K; Richardson, R; Rothbaum, BO | 1 |
| Dadds, MR; Gaston, JE; Guastella, AJ; Lovibond, PF; Mitchell, P; Rapee, RM; Richardson, R | 1 |
7 review(s) available for cycloserine and Claustrophobia
| Article | Year |
|---|---|
Treatment of pediatric anxiety disorders.
Topics: Adolescent; Anticonvulsants; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Riluzole; Stress Disorders, Post-Traumatic | 2013 |
Neuroimaging correlates of pharmacological and psychological treatments for specific phobia.
Topics: Combined Modality Therapy; Cycloserine; Databases, Bibliographic; Excitatory Amino Acid Agonists; Humans; Neuroimaging; Phobic Disorders; Psychotherapy; Statistics as Topic; Treatment Outcome | 2014 |
Social phobia: an update on treatment.
Topics: Benzodiazepines; Combined Modality Therapy; Cycloserine; Diagnosis, Dual (Psychiatry); Diagnostic and Statistical Manual of Mental Disorders; Humans; Monoamine Oxidase Inhibitors; Phobic Disorders; Primary Health Care; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Recent advances in the psychosocial treatment of social anxiety disorder.
Topics: Animals; Anti-Anxiety Agents; Attention; Cognitive Behavioral Therapy; Combined Modality Therapy; Culture; Cycloserine; Humans; Implosive Therapy; Phobic Disorders; Rats; Social Adjustment; Social Perception | 2010 |
Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
Topics: Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Eye Movement Desensitization Reprocessing; Humans; Hypnosis; Implosive Therapy; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Treatment Outcome | 2010 |
Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Topics: Animals; Antimetabolites; Cognitive Behavioral Therapy; Conditioning, Classical; Cycloserine; Extinction, Psychological; Fear; Humans; Phobic Disorders; Receptors, N-Methyl-D-Aspartate | 2006 |
Enhancing exposure-based therapy from a translational research perspective.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders | 2007 |
17 trial(s) available for cycloserine and Claustrophobia
| Article | Year |
|---|---|
D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases.
Topics: Adult; Animals; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Fear; Female; Humans; Male; Phobic Disorders; Spiders | 2020 |
D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Child; Combined Modality Therapy; Cycloserine; Double-Blind Method; Fear; Female; Humans; Implosive Therapy; Male; Phobic Disorders; Pilot Projects; Treatment Outcome | 2018 |
Fear extinction learning as a predictor of response to cognitive behavioral therapy for pediatric obsessive compulsive disorder.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Conditioning, Classical; Cycloserine; Extinction, Psychological; Fear; Female; Humans; Male; Obsessive-Compulsive Disorder; Phobic Disorders; Treatment Outcome | 2019 |
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Female; Humans; Interview, Psychological; Male; Phobic Disorders; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Remission Induction | 2013 |
D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.
Topics: Adult; Black or African American; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Phobic Disorders; Prognosis; Psychotherapy, Group; Social Environment; Temperament; White People | 2013 |
Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
Topics: Adult; Antimetabolites; Behavior Therapy; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cycloserine; Humans; Implosive Therapy; Phobic Disorders; Placebos; Predictive Value of Tests; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2013 |
D-cycloserine enhances generalization of fear extinction in children.
Topics: Animals; Child; Combined Modality Therapy; Cycloserine; Dogs; Double-Blind Method; Extinction, Psychological; Fear; Female; Generalization, Psychological; Humans; Implosive Therapy; Male; Phobic Disorders; Spiders | 2015 |
An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia.
Topics: Adult; Analysis of Variance; Animals; Antibiotics, Antitubercular; Brain; Brain Mapping; Cycloserine; Female; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen; Phobic Disorders; Psychiatric Status Rating Scales; Regression Analysis; Spiders; Surveys and Questionnaires; Young Adult | 2009 |
The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.
Topics: Adolescent; Adult; Animals; Cues; Cycloserine; Double-Blind Method; Fear; Female; Humans; Male; Phobic Disorders; Self Report; Spiders; Subliminal Stimulation | 2012 |
Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Topics: Adult; Animals; Antimetabolites; Brain; Brain Mapping; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Implosive Therapy; Magnetic Resonance Imaging; Male; Middle Aged; Phobic Disorders; Snakes | 2012 |
Augmentation of exposure therapy with post-session administration of D-cycloserine.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antimetabolites; Avoidance Learning; Cycloserine; Female; Humans; Implosive Therapy; Male; Middle Aged; Neuropsychological Tests; Phobic Disorders; Psychiatric Status Rating Scales; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |
A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Topics: Adult; Analysis of Variance; Combined Modality Therapy; Cycloserine; Fear; Female; Humans; Implosive Therapy; Male; Middle Aged; Phobic Disorders; Random Allocation; Receptors, N-Methyl-D-Aspartate; Speech | 2013 |
D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.
Topics: Adult; Cycloserine; Double-Blind Method; Extinction, Psychological; Fear; Female; Follow-Up Studies; Humans; Male; Phobic Disorders; Regression Analysis; Severity of Illness Index; Virtual Reality Exposure Therapy | 2013 |
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Topics: Adult; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Double-Blind Method; Extinction, Psychological; Fear; Female; Humans; Male; Middle Aged; Phobic Disorders; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2004 |
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Topics: Adult; Combined Modality Therapy; Cycloserine; Double-Blind Method; Drug Administration Schedule; Fear; Female; Humans; Implosive Therapy; Male; Phobic Disorders; Placebos; Psychotherapy, Group; Receptors, N-Methyl-D-Aspartate; Speech | 2006 |
A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Topics: Adolescent; Adult; Animals; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Drug Administration Schedule; Extinction, Psychological; Fear; Female; Humans; Male; Middle Aged; N-Methylaspartate; Phobic Disorders; Photic Stimulation; Spiders | 2007 |
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
Topics: Adolescent; Adult; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Double-Blind Method; Fear; Female; Humans; Male; Middle Aged; New South Wales; Phobic Disorders; Premedication; Speech | 2008 |
2 other study(ies) available for cycloserine and Claustrophobia
| Article | Year |
|---|---|
Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies.
Topics: Cognitive Behavioral Therapy; Cycloserine; Female; Humans; Male; Phobic Disorders; Receptors, N-Methyl-D-Aspartate | 2013 |
Society for Neuroscience meeting. Pills and games help conquer fear.
Topics: Animals; Behavior Therapy; Combined Modality Therapy; Controlled Clinical Trials as Topic; Cycloserine; Fear; Humans; Learning; Phobic Disorders; Rats; Receptors, N-Methyl-D-Aspartate; User-Computer Interface | 2003 |